Peptide-Based Drug Predictions for Cancer Therapy Using Deep Learning

Anticancer peptides (ACPs) are selective and toxic to cancer cells as new anticancer drugs. Identifying new ACPs is time-consuming and expensive to evaluate all candidates’ anticancer abilities. To reduce the cost of ACP drug development, we collected the most updated ACP data to train a convolution...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Yih-Yun, Lin, Tzu-Tang, Cheng, Wen-Chih, Lu, I-Hsuan, Lin, Chung-Yen, Chen, Shu-Hwa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028292/
https://www.ncbi.nlm.nih.gov/pubmed/35455418
http://dx.doi.org/10.3390/ph15040422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028292/
https://www.ncbi.nlm.nih.gov/pubmed/35455418
http://dx.doi.org/10.3390/ph15040422

Ejemplares similares